Touching lives
that haven’t yet begun.
FETALSCREEN™ II Fetal Maternal Hemorrhage Screening Test
Announcing a new addition to the Ortho Clinical Diagnostics family of products for the early detection, prevention, and management of Hemolytic Disease of the Newborn (HDN). The FETALSCREEN™ II Screening Test for Detection of D (Rho) positive fetal red blood cells in maternal circulation further expands upon the commitment of Ortho Clinical Diagnostics to help protect mothers and their babies.
FETALSCREEN™ II FMH Test together with RhoGAM® Brand provides a platform to aid in the screening and prevention of HDN. Rh-negative women with a fetomaternal hemorrhage (FMH) of Rh-positive blood are at increased risk of Rh immunization and the outcome of their current and future pregnancies may be affected.